<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport Begins Delivering Novel Cryogenically Preserved Knee OA Treatment to Orthopedists

October 14, 2014

Lake Forest, CA (October 14, 2014) - Cryoport, Inc. (OTC:CYRX) announced today the first phase of deploying its “Regenerative Medicine Point-of-Care Repository Solution” for Liventa Bioscience’s introduction of Liventa’s AmnioClear® LCT therapy to orthopedic clinics in the US. More than 70 orthopedic clinics have expressed interest in the therapy. Of these clinics, approximately 20 have entered into a registry/ clinical study with Liventa.  

Read More


Tags: Frozen Shipping, Liventa, Regenerative Medicine Point-of-Care Repository Sol, AmnioClear®, Cold Chain Logistics, Dry Shipper, cold shipping

Cryoport Engages Broekman Group to Enhance Its Logistics and Operational Support in Europe

September 16, 2014

LAKE FOREST, CA – September 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the world’s leading provider of advanced cryogenic logistics solutions for the life-sciences industry, announced today that it has engaged Broekman Group, a global logistics company headquartered in Rotterdam, the Netherlands, to provide support to their rapidly expanding European client base. According to the terms of the agreement, Broekman’s European operations will support Cryoport’s leading-edge cryogenic logistics solutions throughout Europe.

Read More


Tags: Frozen Shipping, Europe, Broekman Group, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Appoints VP of Strategic Business Development and Accelerates Expansion of Direct Sales Force

September 8, 2014

LAKE FOREST, CA – September 8, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences industry, announced today the appointment of Curt Kole to the new role of VP, Strategic Business Development. Cryoport’s new business development personnel will support the Company’s rapid development and integration of large-scale corporate clients. In addition to securing new business sectors and major accounts for Cryoport, this new function will be responsible for the management of many key partnerships for the Company.

Read More


Tags: Frozen Shipping, sales, business development, Curt Kole, VP of Strategic Business Development, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport to Present at the Aegis Healthcare & Technology Conference on September 12, 2014

September 2, 2014

LAKE FOREST, CA – September 2, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today that its Chief Financial Officer, Robert Stefanovich, is scheduled to present at the Aegis Healthcare & Technology Conference on Friday, September 12, 2014 at 1:30 pm PT, at The Encore at Wynn Las Vegas.

Read More


Tags: Frozen Shipping, Aegis Healthcare & Technology Conference, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Expands Sales Force to Meet Increasing Demand

August 12, 2014

LAKE FOREST, CA – August 12, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, announced today the implementation of its sales force expansion program to accelerate the Company’s rapidly expanding customer base.  In addition to our key market sectors, the expanded sales team will provide direct support to our global integrator partners, who uniquely employ Cryoport’s ‘powered by Cryoport’ solutions into their respective strategies for the life sciences cold chain.

Read More


Tags: Frozen Shipping, sales, business development, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015

July 31, 2014

LAKE FOREST, CA – July 31, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three month period ended June 30, 2014.  

Recent Operating Highlights

Read More


Tags: Frozen Shipping, Revenue, first quarter fiscal 2015, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport and DHL Partner to Provide Cryogenic Logistics Solutions for Life Sciences and Healthcare Clients

July 16, 2014

LAKE FOREST, CA – July 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, partners with LifeConEx, a  part of DHL Global Forwarding, to enhance and supplement DHL’s cold chain logistics offerings including DHL Express’ Medical Express to its life sciences and healthcare customers with Cryoport’s comprehensive cryogenic logistics solutions.

Read More


Tags: Frozen Shipping, DHL, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Launches Free Investor Relations App

July 1, 2014

LAKE FOREST, CA – July 1, 2014 – Cryoport, Inc. (OTCBB: CYRX) (“the Company”) today announced the release of its investor relations app for iPhone, iPad and Android mobile devices now available for free at Apple’s App Store for the iPhone and iPad https://itunes.apple.com/us/app/cryoport-investor-relations/id878258991?ls=1&mt=8 and at Google Play https://play.google.com/store/apps/details?id=com.theirapp.cryoport for Android mobile devices.

Read More


Tags: Frozen Shipping, Investor relations app, free, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Immudex Selects Cryoport to Manage Cold Chain Logistics of Biologic Samples and Proficiency Panels Worldwide

June 23, 2014

LAKE FOREST, CA – June 23, 2014 – Cryoport, Inc. (OTCBB: CYRX) (“the Company”) today announced that it has been chosen by Immudex to support its global distribution of biological materials and samples for proficiency panels to and from Immudex’s production and research facilities and customers.

Read More


Tags: Frozen Shipping, Immudex, Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics

Cryoport Announces Appointment of Ramkumar Mandalam, Ph.D. to Board of Directors

June 16, 2014

LAKE FOREST, CA – June 16, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading, global provider of advanced cryogenic logistics solutions, today announced the appointment of Ramkumar Mandalam, Ph.D., to its Board of Directors. Additionally, he has been appointed to serve as a member of the Compensation and Nominating and Governance Committees. Following Dr. Mandalam’s appointment, Cryoport’s Board of Directors will have a total of five members, including four independent members.           

Read More


Tags: Frozen Shipping, shipping solution, Frozen, board, Ramkumar Mandalam, Ph.D., Cold Chain Logistics, Dry Shipper, cold shipping, Clinical Trials Logistics